Evaluation of the topical effect of simvastatin on improving wound healing in diabetic patients
Phase 2
Recruiting
- Conditions
- Diabetic foot ulcer.Type 1 diabetes mellitus with circulatory complicationsE10.5
- Registration Number
- IRCT20191010045051N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diabetic patients with foot ulcer in grade 2 or 3
Exclusion Criteria
Diabetic patients with foot ulcers with a wound surface greater than 10 cm
Patients in need of amputation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wound area. Timepoint: Measurement of wound area at baseline and 14 and 28 days after topical cream application. Method of measurement: Ruler.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: 14 and 28 days after topical cream application. Method of measurement: Number of hospital stay days.